Ticker: APLS

Company: Apellis Pharmaceuticals, Inc.

Person: Cedric Francois, director, officer

Transaction date: Feb. 3, 2026

Reporting date: Feb. 5, 2026

Average share price: 3.7600000000000002

Bought 8840.0 shares for 33238.4